Sudocrem boss: new skin drug will net €1.5bn - Raglan Capital

Home
About Us
Selected Transactions
Raglan IPO Projects
- Raglan Pharmaceutical & Life Science Projects
- Raglan Natural Resources
News
Contact us

Search

Sudocrem boss: new skin drug will net €1.5bn

Home
Amryt Pharma
Sudocrem boss: new skin drug will net €1.5bn

Recent News

Coronavirus: Canada suspends use of AstraZeneca shot for under-55s – as it happened
World’s first trial of deliberate coronavirus infection is approved
Scientists win approval to infect healthy volunteers with Covid for trial
Open Orphan gets final go-ahead for Covid-19 human trial
Covid-19: World’s first human challenge trials to start in UK
COVID-19: Volunteers to be exposed to virus in world-first study in UK

10 April 2016

Sudocrem boss: new skin drug will net €1.5bn 10 April 2016 online article

Prev
Next

Join us for our newsletters

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

Contact us
Careers
Privacy Policy
Cookie policy (EU)

Join us for our newsletters

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

Contact us
Careers
Privacy Policy
Cookie policy (EU)

© 2021 Raglan Capital. All rights reserved

Privacy Preference Center

Privacy Preferences